sEH Antibodies

Santa Cruz Biotechnology delivers a wide array of sEH monoclonal antibodies for the specific detection and analysis of soluble epoxide hydrolase (sEH). sEH Antibodies are suitable for research applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Soluble epoxide hydrolase plays a critical role in the metabolism of epoxyeicosatrienoic acids (EETs), which are important signaling molecules involved in cardiovascular health, inflammation, and pain modulation. By regulating the levels of EETs, sEH influences various physiological processes, making it a significant target for research in cardiovascular diseases and other metabolic disorders. Understanding the function of sEH and its impact on cellular signaling pathways is essential for developing therapeutic strategies. Research into sEH has revealed its significance in multiple biological pathways and potential therapeutic applications. Investigating sEH mechanisms can provide valuable insights into disease progression and treatment options. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing scientific understanding of soluble epoxide hydrolase.